Literature DB >> 212415

Fructose-1,6-biphosphatase of the small intestine. Purification and comparison with liver and muscle fructose-1,6-bisphosphatases.

H Mizunuma, Y Tashima.   

Abstract

The occurrence of specific fructose-1,6-bisphosphatase [D-fructose-1,6-bisphosphate 1-phosphohydrolase, EC 3.1.3.11] (Fru-1,6-P2ase) in the small intestine was confirmed. 1. Fru-1,6-P2ase was isolated from mouse small intestine by a simple method. The isolated enzyme preparation was an electrophoretically homogeneous protein. 2. The molecular weight and subunit molecular weight were 140,000 and 38,000, respectively. 3. The intestinal enzyme was electrophoretically distinct from the liver enzyme. 4. The kinetic properties of the purified intestinal enzyme were compared with those of the mouse liver and muscle enzymes. 5. Mouse intestinal and muscle Fru-1,6-P2ases hydrolyzed ribulose-1,5-bisphosphate in addition to fructose-1,6-bisphosphate and sedoheptulose-1,7-bisphosphate.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 212415     DOI: 10.1093/oxfordjournals.jbchem.a132132

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  4 in total

1.  Kinetic properties of D-fructose-1,6-bisphosphate 1-phosphohydrolase isolated from human muscle.

Authors:  K Skalecki; W Mularczyk; A Dzugaj
Journal:  Biochem J       Date:  1995-09-15       Impact factor: 3.857

2.  Fructose bisphosphatase isozymes of the mouse. I. Inheritance.

Authors:  H R Nash; P R Challinor
Journal:  Biochem Genet       Date:  1985-08       Impact factor: 1.890

3.  The involvement of fructose 2,6-bisphosphate in substrate cycle control in the nonoxidative stage of the pentose phosphate pathway. A phosphorus magnetic resonance spectroscopy study.

Authors:  N F Belyaeva; M A Golubev; J A Grigorovich; Z V Dubinsky; N A Semenova; E Pitkänen; B F Korovkin
Journal:  Experientia       Date:  1994-08-15

4.  FBP1 expression is associated with basal-like breast carcinoma.

Authors:  Lei Shi; Chunbo Zhao; Haihong Pu; Qingyuan Zhang
Journal:  Oncol Lett       Date:  2017-03-14       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.